Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis

View through CrossRef
Abstract Background In December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged with a high transmissibility rate and resulted in numerous negative impacts on global life. Preventive measures such as facial masks, social distancing, and vaccination helped control the pandemic. Nonetheless, the emergence of SARS-CoV-2 variants, such as Omega and Delta, as well as coronavirus disease 2019 (COVID-19) reinfection, raise additional concerns. Therefore, this study aimed to determine the overall prevalence of reinfection on global and regional scales. Methods A systematic search was conducted across three databases, PubMed, Scopus, and ProQuest Central, including all articles pertaining to COVID-19 reinfection without language restriction. After critical appraisal and qualitative synthesis of the identified relevant articles, a meta-analysis considering random effects was used to pool the studies. Results We included 52 studies conducted between 2019 and 2022, with a total sample size of 3,623,655 patients. The overall prevalence of COVID-19 reinfection was 4.2% (95% confidence interval [CI]: 3.7–4.8%; n = 52), with high heterogeneity between studies. Africa had the highest prevalence of 4.7% (95% CI: 1.9–7.5%; n = 3), whereas Oceania and America had lower estimates of 0.3% (95% CI: 0.2–0.4%; n = 1) and 1% (95% CI: 0.8–1.3%; n = 7), respectively. The prevalence of reinfection in Europe and Asia was 1.2% (95% CI: 0.8–1.5%; n = 8) and 3.8% (95% CI: 3.4–4.3%; n = 43), respectively. Studies that used a combined type of specimen had the highest prevalence of 7.6% (95% CI: 5.8–9.5%; n = 15) compared with those that used oropharyngeal or nasopharyngeal swabs only that had lower estimates of 6.7% (95% CI: 4.8–8.5%; n = 8), and 3.4% (95% CI: 2.8–4.0%; n = 12) respectively. Conclusion COVID-19 reinfection occurs with varying prevalence worldwide, with the highest occurring in Africa. Therefore, preventive measures, including vaccination, should be emphasized to ensure control of the pandemic.
Title: Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis
Description:
Abstract Background In December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged with a high transmissibility rate and resulted in numerous negative impacts on global life.
Preventive measures such as facial masks, social distancing, and vaccination helped control the pandemic.
Nonetheless, the emergence of SARS-CoV-2 variants, such as Omega and Delta, as well as coronavirus disease 2019 (COVID-19) reinfection, raise additional concerns.
Therefore, this study aimed to determine the overall prevalence of reinfection on global and regional scales.
Methods A systematic search was conducted across three databases, PubMed, Scopus, and ProQuest Central, including all articles pertaining to COVID-19 reinfection without language restriction.
After critical appraisal and qualitative synthesis of the identified relevant articles, a meta-analysis considering random effects was used to pool the studies.
Results We included 52 studies conducted between 2019 and 2022, with a total sample size of 3,623,655 patients.
The overall prevalence of COVID-19 reinfection was 4.
2% (95% confidence interval [CI]: 3.
7–4.
8%; n = 52), with high heterogeneity between studies.
Africa had the highest prevalence of 4.
7% (95% CI: 1.
9–7.
5%; n = 3), whereas Oceania and America had lower estimates of 0.
3% (95% CI: 0.
2–0.
4%; n = 1) and 1% (95% CI: 0.
8–1.
3%; n = 7), respectively.
The prevalence of reinfection in Europe and Asia was 1.
2% (95% CI: 0.
8–1.
5%; n = 8) and 3.
8% (95% CI: 3.
4–4.
3%; n = 43), respectively.
Studies that used a combined type of specimen had the highest prevalence of 7.
6% (95% CI: 5.
8–9.
5%; n = 15) compared with those that used oropharyngeal or nasopharyngeal swabs only that had lower estimates of 6.
7% (95% CI: 4.
8–8.
5%; n = 8), and 3.
4% (95% CI: 2.
8–4.
0%; n = 12) respectively.
Conclusion COVID-19 reinfection occurs with varying prevalence worldwide, with the highest occurring in Africa.
Therefore, preventive measures, including vaccination, should be emphasized to ensure control of the pandemic.

Related Results

Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
This review summarizes the evidence from six randomized controlled trials that judged the effectiveness of systematic review summaries on policymakers' decision making, or the most...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Outcomes of SARS-CoV-2 Reinfection
Outcomes of SARS-CoV-2 Reinfection
Abstract First infection with SARS-CoV-2 is associated with increased risk of acute and post-acute death and sequelae in the pulmonary and extrapulmonary organ systems. How...
Recurrence Possibility of COVID-19 in India
Recurrence Possibility of COVID-19 in India
Although nationwide lockdown was imposed in India amid COVID-19 outbreak since March 24, 2020, the COVID-19 infection is increasing day-by-day. India became world’s second most aff...
Predictors of severe symptomatic laboratory-confirmed SARS-COV-2 reinfection
Predictors of severe symptomatic laboratory-confirmed SARS-COV-2 reinfection
AbstractBackgroundThere is a major concern regarding the prognosis of coronavirus disease 2019 (COVID-19) in patients who recovered to first-time illness.ObjectiveTo evaluate facto...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...

Back to Top